Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
The largest genetic study on Alzheimer's disease to date has uncovered 48 previously unknown DNA risk regions and found that common genetic variants explain far more of the disease risk than previously thought. Analyzing data from 2.8 million people, researchers pinpointed key roles for brain immune cells (microglia) and specific neuron types. The findings open new doors for drug target discovery and future therapies.
An international team of researchers, led by Ole Andreassen at the University of Oslo, has published the largest-ever genetic association study on Alzheimer's disease in Nature. By pooling data from 30 research groups — covering roughly 2.8 million individuals — the team identified 127 DNA regions linked to Alzheimer's risk, including 48 that had never been flagged before. The findings shine a spotlight on microglia (the brain's immune cells) and, for the first time, specific neuron types that appear to play a meaningful role in disease development.
Perhaps the most striking revelation: common genetic variants collectively explain about 16% of the variation in Alzheimer's risk between people — nearly three times the previous estimate of ~5%. Researchers credit a more sophisticated statistical method that better accounts for the APOE gene's outsized influence.
By the Numbers:
Why it matters: These findings give scientists a much more detailed map of the biology driving Alzheimer's — pointing to new drug targets and research directions. While a genetic test still can't predict individual risk, this study accelerates the path toward precision therapies for the world's leading cause of dementia.
